{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11421736", "DateCompleted": {"Year": "2001", "Month": "08", "Day": "30"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "64", "Issue": "6", "PubDate": {"Year": "2001", "Month": "Jun"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Cox-2 inhibitory effects of naturally occurring and modified fatty acids.", "Pagination": {"StartPage": "745", "EndPage": "749", "MedlinePgn": "745-9"}, "Abstract": {"AbstractText": ["In the search for new cyclooxygenase-2 (COX-2) selective inhibitors, the inhibitory effects of naturally occurring fatty acids and some of their structural derivatives on COX-2-catalyzed prostaglandin biosynthesis were investigated. Among these fatty acids, linoleic acid (LA), alpha-linolenic acid (alpha-LNA), myristic acid, and palmitic acid were isolated from a CH(2)Cl(2) extract of the plant Plantago major by bioassay-guided fractionation. Inhibitory effects of other natural, structurally related fatty acids were also investigated: stearic acid, oleic acid, pentadecanoic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). Further, the inhibitory effects of these compounds on COX-2- and COX-1-catalyzed prostaglandin biosynthesis was compared with the inhibition of some synthesized analogues of EPA and DHA with ether or thioether functions. The most potent COX-2-catalyzed prostaglandin biosynthesis inhibitor was all-(Z)-5-thia-8,11,14,17-eicosatetraenoic acid (2), followed by EPA, DHA, alpha-LNA, LA, (7E,11Z,14Z,17Z)-5-thiaeicosa-7,11,14,17-tetraenoic acid, all-(Z)-3-thia-6,9,12,15-octadecatetraenoic acid, and (5E,9Z,12Z,15Z,18Z)-3-oxaheneicosa-5,9,12,15,18-pentaenoic acid, with IC(50) values ranging from 3.9 to180 microM. The modified compound 2 and alpha-LNA were most selective toward COX-2, with COX-2/COX-1 ratios of 0.2 and 0.1, respectively. This study shows that several of the natural fatty acids as well as all of the semisynthetic thioether-containing fatty acids inhibited COX-2-catalyzed prostaglandin biosynthesis, where alpha-LNA and compound 2 showed selectivity toward COX-2."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacognosy, Department of Medicinal Chemistry, Biomedical Centre, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden."}], "Identifier": [], "LastName": "Ringbom", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huss", "ForeName": "U", "Initials": "U"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Stenholm", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Flock", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Skatteb\u00f8l", "ForeName": "L", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Perera", "ForeName": "P", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bohlin", "ForeName": "L", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase 2 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoenzymes"}, {"RegistryNumber": "0", "NameOfSubstance": "Prostaglandin Antagonists"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 1"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Prostaglandin-Endoperoxide Synthases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cattle"}, {"QualifierName": [], "DescriptorName": "Cyclooxygenase 1"}, {"QualifierName": [], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": [], "DescriptorName": "Cyclooxygenase 2 Inhibitors"}, {"QualifierName": ["chemical synthesis", "isolation & purification", "pharmacology"], "DescriptorName": "Cyclooxygenase Inhibitors"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Fatty Acids"}, {"QualifierName": ["metabolism"], "DescriptorName": "Isoenzymes"}, {"QualifierName": [], "DescriptorName": "Methylation"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Microsomes"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plantago"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Prostaglandin Antagonists"}, {"QualifierName": ["metabolism"], "DescriptorName": "Prostaglandin-Endoperoxide Synthases"}, {"QualifierName": [], "DescriptorName": "Sheep"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "6", "Day": "26", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "8", "Day": "31", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "6", "Day": "26", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11421736", "10.1021/np000620d", "np000620d"]}}], "PubmedBookArticle": []}